New aromatic inhibitors of EPSP synthase incorporating hydroxymalonates as novel 3-phosphate replacements

A new, aromatic analogue of the EPSP synthase enzyme reaction intermediate 1 has been identified, which contains a 3-hydroxymalonate moiety in place of the usual 3-phosphate group. This simplified inhibitor was readily prepared in five steps from ethyl 3,4-dihydroxybenzoate. The resulting tetrahedra...

Full description

Saved in:
Bibliographic Details
Published inBioorganic & medicinal chemistry Vol. 5; no. 2; pp. 323 - 334
Main Authors Shah, Ajit, Font, Jose L., Miller, Michael J., Ream, Joel E., Walker, Mark C., Sikorski, James A.
Format Journal Article
LanguageEnglish
Published England Elsevier Ltd 01.02.1997
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A new, aromatic analogue of the EPSP synthase enzyme reaction intermediate 1 has been identified, which contains a 3-hydroxymalonate moiety in place of the usual 3-phosphate group. This simplified inhibitor was readily prepared in five steps from ethyl 3,4-dihydroxybenzoate. The resulting tetrahedral intermediate mimic 9 is an effective, competitive inhibitor versus S3P with an apparent K i of 0.57±0.06 μM. This result demonstrates that 3-hydroxymalonates exhibit potencies comparable to aromatic inhibitors containing the previously identified 3-malonate ether replacements and can thus function as suitable 3-phosphate mimics in this system. These new compounds provide another example in which a simple benzene ring can be used effectively in place of the more complex shikimate ring in the design of EPSP synthase inhibitors. Furthermore, the greater potency of 9 versus the glycolate derivative 10 and the 5-deoxy-analog 11, again confirms the requirement for multiple anionic charges at the dihydroxybenzoate 5-position in order to attain effective inhibition of this enzyme. All rights reserved. Aromatic analogues of the EPSP synthase reaction substrate, product, and tetrahedral intermediate were synthesized from 3,4-dihydroxybenzoic acid, containing a 3-hydroxymalonate in place of the normal 3-phosphate group. These molecules help define the scope and limitations of incorporating 3-hydroxymalonates as 3-phosphate replacements in this system.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0968-0896
1464-3391
DOI:10.1016/S0968-0896(96)00239-8